Fig. 9
From: Establishing and validating a new metabolic marker-driven prognosis signature for cutaneous melanoma
Knockdown of GALNT2 inhibited cell proliferation and migration capacity. Edu assays. Western blotting was performed to assess the transfection efficiency of GALNT2 in A375 and A2058 cells (A,B). Edu assays (C,D) and colony formation assays (E,F) were performed to assess the effect of siGALNT2 expression on A375 and A2058 proliferation. Wound healing assays (G,H) and Transwell assays (I,J) were performed to assess the effect on A375 and A2058 migration after interfering with GALNT2 expression. (**p < 0.01,***p < 0.001).
